Breast Cancer

Showing NaN - NaN of 215

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Johns Hopkins Breast Cancer Program Longitudinal Repository

Recruiting
  • Breast Cancer
  • Benign Breast Disease
  • Sample collection
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 20, 2022

Breast Cancer Trial in Ireland, United States (bevacizumab, docetaxel, doxorubicin)

Completed
  • Breast Cancer
  • Bessemer, Alabama
  • +532 more
Apr 13, 2022

Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)

Recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +3 more
Apr 15, 2022

Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)

Active, not recruiting
  • Breast Cancer
  • Mobile, Alabama
  • +437 more
Mar 21, 2022

Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Renal Cell Carcinoma
  • IPI-549 (eganelisib)
  • +3 more
  • Chandler, Arizona
  • +23 more
Apr 1, 2022

Breast Cancer Trial in United States (Trastuzumab, Paclitaxel, Trastuzumab emtansine)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +84 more
Mar 15, 2022

Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)

Terminated
  • Triple-Negative Breast Neoplasms
  • +3 more
  • Tucson, Arizona
  • +53 more
Feb 24, 2022

99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer

Recruiting
  • Breast Cancer
  • 99m Tc-TM
  • Baltimore, Maryland
    Johns Hopkins Bayview Hospital
Mar 7, 2022

Cardiotoxicity in Breast Cancer Patients Treated With Proton or

Enrolling by invitation
  • Breast Cancer
  • Cardiotoxicity
  • Proton vs Photon Radiation
  • Birmingham, Alabama
  • +5 more
Mar 4, 2022

Breast Cancer Trial in Washington, Baltimore, Boston (Ribociclib)

Recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +3 more
Feb 15, 2022

Tamoxifen in Breast Cancer and in Women at High-Risk of Breast

Active, not recruiting
  • Breast Cancer
  • +3 more
  • citalopram hydrobromide
  • +10 more
  • Indianapolis, Indiana
  • +3 more
Feb 18, 2022

Breast Cancer Trial in Washington, Baltimore (Stereotactic Body Radiation SBRT)

Recruiting
  • Breast Cancer
  • Stereotactic Body Radiation SBRT
  • Washington, District of Columbia
  • +1 more
Jan 24, 2022

Breast Cancer Trial in Canada, Puerto Rico, United States (pegfilgrastim, AC regimen, cyclophosphamide)

Active, not recruiting
  • Breast Cancer
  • pegfilgrastim
  • +4 more
  • Anniston, Alabama
  • +541 more
Jan 19, 2022

Breast Cancer Trial in United States (The Gamma Pod, CT simulation)

Completed
  • Breast Cancer
  • The Gamma Pod
  • CT simulation
  • Baltimore, Maryland
  • +3 more
Jan 5, 2022

Postoperative Pain, Postoperative Nausea and Vomiting, Quality of Life Trial in Baltimore (Pre-pectoral Tissue Expander)

Completed
  • Postoperative Pain
  • +4 more
  • Pre-pectoral Tissue Expander
  • Baltimore, Maryland
    The Johns Hopkins University
Dec 15, 2021

Breast Cancer Trial in Baltimore (FBnTP)

Terminated
  • Breast Cancer
  • Baltimore, Maryland
    Johns Hopkins Hospital
Dec 14, 2021

Breast Cancer Trial in Baltimore (Tamoxifen Citrate, Letrozole, Exemestane)

Recruiting
  • Breast Cancer
  • Tamoxifen Citrate
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins Bayview Hospital
Nov 30, 2021

Breast Cancer Trial in United States (GammaPod Radiation)

Recruiting
  • Breast Cancer
  • GammaPod Radiation
  • Baltimore, Maryland
  • +3 more
Nov 8, 2021

Breast Cancer, Breast Tumor, Breast Tumor Trial in United States (Proton Radiotherapy)

Recruiting
  • Breast Cancer
  • +3 more
  • Proton Radiotherapy
  • San Diego, California
  • +6 more
Oct 24, 2021

Breast Cancer, Breast Tumor, Breast Tumor Trial in United States (Proton Radiotherapy)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Proton Radiotherapy
  • Warrenville, Illinois
  • +4 more
Oct 24, 2021

Breast Cancer Trial in Canada, Ireland, United States (Letrozole, Placebo)

Active, not recruiting
  • Breast Cancer
  • Anniston, Alabama
  • +805 more
Oct 4, 2021

Breast Cancer Trial in Worldwide (Placebo, Denosumab)

Terminated
  • Breast Cancer
  • Birmingham, Alabama
  • +458 more
Sep 1, 2021

Metastasis, Breast Cancer Trial in Worldwide (NKTR-102, Eribulin, Ixabepilone)

Completed
  • Metastasis
  • Breast Cancer
  • Tucson, Arizona
  • +55 more
Aug 3, 2021

Breast Cancer Trial in Baltimore (AZD9496 (Reference), AZD9496 Variant A, AZD9496 Variant B)

Completed
  • Breast Cancer
  • AZD9496 (Reference)
  • +4 more
  • Baltimore, Maryland
    Research Site
Aug 2, 2021

Cardiac MRI Biomarker Testing (GCC 1618)

Recruiting
  • Breast Cancer
  • +4 more
  • Complete Cardiac Magnetic Resonance Imaging (MRI)
  • Baltimore, Maryland
    Ummc Msgccc
Aug 16, 2021